Skip to main content

Supplementierung inklusive therapeutische Formelnahrung

  • Chapter
  • 7817 Accesses

Zusammenfassung

Einer der Unterschiede in der Zusammensetzung von Muttermilch und künstlichen Säuglingsnahrungen auf Kuhmilchbasis besteht im Gehalt an langkettigen mehrfach ungesättigten Fettsäuren („long chain polyunsaturated fatty acids“, LCPUFA). Die Zugabe von Nervon-, Docosapentaen- und Docosahexaensäure zu Formulamilchen wurde empfohlen (Sala-Vila et al. 2004) und inzwischen teilweise von den Herstellern umgesetzt, obwohl auch festgestellt wurde, dass dies keinen Vorteil erbringt, wenn bereits 10 % der Energie als Linolensäure und 1 % als α-Linolensäure zugeführt werden (Auestad et al. 2004).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Agostoni C, Verduci E, Massetto N et al. (2003) Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria. Develop Med Child Neurol 45: 257–261

    Article  PubMed  Google Scholar 

  • Agostoni C, Braegger C, Decsi T et al. (2011) Supplementation of N-3 LCPUFA to the diet of children older than 2 years: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 53(1): 2–10

    Article  PubMed  CAS  Google Scholar 

  • Antalis CJ, Stevens LJ, Campbell M et al. (2006) Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukotrienes Essential Fatty Acids 75: 299–308

    Article  CAS  Google Scholar 

  • Auestad N, Halter R, Hall RT et al. (2004) Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study. Pediatrics 108(2): 372–381

    Article  Google Scholar 

  • Cleary MA, Feillet F, White FJ et al. (2006) Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. Eur J Clin Nutr 60: 915–920

    Article  PubMed  CAS  Google Scholar 

  • Colombo C, Bennato V, Costantini D et al. (2006) Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: Are they related to clinical outcomes? JPGN 43: 660–665

    PubMed  CAS  Google Scholar 

  • Crooke RM, Graham MJ, Lemonidis KM et al. (2005) An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res 46: 872–884

    Article  PubMed  CAS  Google Scholar 

  • Durrington PN, Bhatnagar D, Mackness MI et al. (2001) An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 85(5): 544–548

    Article  PubMed  CAS  Google Scholar 

  • Fell JME, Paintin M, Arnaud-Battandier F et al. (2000) Mucosal healing and a fall in mucosal proinflammatory cytokine mRNA induced by a specific oral polymeric diet in pediatric Crohn’s disease. Aliment Pharmacol Ther 14: 281–289

    Article  PubMed  CAS  Google Scholar 

  • Gassull MA, Cabre E (2001) Nutrition in inflammatory bowel disease. Curr Opin Clin Nutrition Metab Care 4: 561–569

    Article  CAS  Google Scholar 

  • Hadders-Algra M, Bouwstra H, Goor SA van et al. (2007) Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J Perinat Med 35: S28–S34

    Article  PubMed  CAS  Google Scholar 

  • Joshi K, Lad S, Kale M et al. (2006) Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins Leukotrienes Essential Fatty Acids 74: 17–21

    Article  CAS  Google Scholar 

  • Jürgens K, Kraft J, Jahreis G (2007) Ernährung von Patienten mit Adrenoleukodystrophie und Adrenomyeloneuropathie. Ernährungsumschau 4: 188–193

    Google Scholar 

  • Kalivianakis M, Minich DM, Bijleveld CMA et al. (1999) Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69: 127–134

    PubMed  CAS  Google Scholar 

  • Martínez M, Vázquez E, García-Silva MT et al. (2000) Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. Am J Clin Nutr 71: 376S–385S

    PubMed  Google Scholar 

  • Miyazawa R, Tomomasa T, Kaneko H et al. (2006) Effect of formula thickened with locust bean gum on gastric emptying in infants. J Paediatr Child Health 42: 808–812

    Article  PubMed  Google Scholar 

  • Moser AB, Jones DS, Raymond GV et al. (1999) Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem Res 24 (2): 187–197

    Article  PubMed  CAS  Google Scholar 

  • Paker AM et al (2010) Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial.Neurology 75(9): 826–830

    Article  PubMed  CAS  Google Scholar 

  • Sala-Vila A, Castellote AI, Campoy C et al. (2004) The source of long-chain PUFA in formula supplements does not affect the fatty acid composition of plasma lipids in full-term infants. J Nutr 134: 868–873

    PubMed  CAS  Google Scholar 

  • Simmer K, Patole SK, Rao SC (2008) Longchain polyunsaturated fatty acid supplementation in infants born at term.Cochrane Database Syst Rev 1: CD000376

    PubMed  Google Scholar 

  • Socha P, Ryzko J, Koletzko B et al. (2005) Essential fatty acid depletion in children with inflammatory bowel disease. Scand J Gastroenterol 40: 573–577

    Article  PubMed  CAS  Google Scholar 

  • Vandenplas Y, Belli D, Benhamou PH et al. (1996) Current concepts and issues in the management of regurgitation of infants: A reappraisal. Acta Paediatr 85: 531–534

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Krawinkel, M.B. (2013). Supplementierung inklusive therapeutische Formelnahrung. In: Rodeck, B., Zimmer, KP. (eds) Pädiatrische Gastroenterologie, Hepatologie und Ernährung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24710-1_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-24710-1_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-24709-5

  • Online ISBN: 978-3-642-24710-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics